Free Trial
ASX:NRX

Noronex (NRX) Stock Price, News & Analysis

About Noronex Stock (ASX:NRX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
A$7.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Noronex and its competitors with MarketBeat's FREE daily newsletter.

NRX Stock News Headlines

Insider Buys Additional AU$100k In Noronex Stock
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
FDA aligns with NRx on pediatric depression drug study
See More Headlines

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Copper
Sub-Industry
N/A
Current Symbol
ASX:NRX
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$2.51 million
Net Margins
-4,763.79%
Pretax Margin
N/A
Return on Equity
-83.82%
Return on Assets
-44.27%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.68
Quick Ratio
4.82

Sales & Book Value

Annual Sales
A$8.38 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
A$0.01 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
496,400,000
Free Float
N/A
Market Cap
A$7.99 million
Optionable
Not Optionable
Beta
2.35
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (ASX:NRX) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners